Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Flora Chik"'
Autor:
Flora Chik, Shafaat A. Rabbani, Moshe Szyf, Ani Arakelian, Surabhi Parashar, Nicholas Shukeir, Barbara Stefanska
Publikováno v:
British Journal of Pharmacology. 172:2769-2781
Background and Purpose DNA hypomethylation was previously implicated in metastasis. In the present study, we examined whether methyl supplementation with the universal methyl donor S-adenosylmethionine (SAM) inhibits prostate cancer associated skelet
Autor:
Feldman, Steven R.1, Guerin, Annie2, Gauthier-Loiselle, Marjolaine2, Claxton, Ami J.3, Hazra, Nisha C.4 Nisha.Hazra@analysisgroup.com, Meng, Yan4, Gallant, Kirsten4, Balu, Sanjeev3
Publikováno v:
Journal of Dermatological Treatment. Dec2024, Vol. 35 Issue 1, p1-9. 9p.
Autor:
Moshe Szyf, Michael Hallett, Bishnu Bhattacharya, Chen Chen Li, Matthew Suderman, Ani Arakelian, Flora Chik, Shafaat A. Rabbani, David Cheishvili
Publikováno v:
Carcinogenesis. 35(11)
5-Aza-2ʹ-deoxycytidine (5-azaCdR) not only inhibits growth of non-invasive breast cancer cells but also increases their invasiveness through induction of pro-metastatic genes. Methylated DNA binding protein 2 (MBD2) is involved in silencing methylat
Publikováno v:
Carcinogenesis. 35(1)
DNA-demethylating agents activate tumor suppressor genes that are silenced by DNA methylation in cancer and are therefore emerging as a novel approach to cancer therapy. 5-azacytidine (VIDAZA), the first representative of this class of drugs was appr
Autor:
Schein, Jeff (AUTHOR), Cloutier, Martin (AUTHOR), Gauthier-Loiselle, Marjolaine (AUTHOR), Catillon, Maryaline (AUTHOR), Meng, Yan (AUTHOR), Libchaber, Beatrice (AUTHOR), Jiang, Fanny (AUTHOR), Childress, Ann (AUTHOR)
Publikováno v:
Patient Preference & Adherence. Aug2024, Vol. 18, p1651-1664. 14p.
Autor:
Muntoni, Francesco1 (AUTHOR), Signorovitch, James2,3 (AUTHOR) James.signorovitch@analysisgroup.com, Sajeev, Gautam2 (AUTHOR), Done, Nicolae2 (AUTHOR), Yao, Zhiwen2 (AUTHOR), Goemans, Nathalie4 (AUTHOR), McDonald, Craig5 (AUTHOR), Mercuri, Eugenio6 (AUTHOR), Niks, Erik H.7 (AUTHOR), Wong, Brenda8 (AUTHOR), Vandenborne, Krista9 (AUTHOR), Straub, Volker10 (AUTHOR), de Groot, Imelda J. M.11 (AUTHOR), Tian, Cuixia12 (AUTHOR), Manzur, Adnan1 (AUTHOR), Dieye, Ibrahima2 (AUTHOR), Lane, Henry2 (AUTHOR), Ward, Susan J.3 (AUTHOR), Servais, Laurent13,14 (AUTHOR)
Publikováno v:
PLoS ONE. 7/10/2024, Vol. 19 Issue 7, p1-18. 18p.
Autor:
Schein, Jeff1, Cloutier, Martin2, Gauthier-Loiselle, Marjolaine2, Bungay, Rebecca2 Rebecca.Bungay@analysisgroup.com, Chen, Kathleen2, Chan, Deborah2, Guerin, Annie2, Childress, Ann3
Publikováno v:
Child & Adolescent Psychiatry & Mental Health. 7/8/2024, Vol. 18 Issue 1, p1-10. 10p.
Publikováno v:
Advances in experimental medicine and biology. 720
The epigenome which comprises DNA methylation, histone modifications, chromatin structures and non-coding RNAs controls gene expression patterns. In cancer cells, there are aberrant changes in the epigenome. The question in cancer epigenetics is that
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781461402534
The epigenome which comprises DNA methylation, histone modifications, chromatin structures and non-coding RNAs controls gene expression patterns. In cancer cells, there are aberrant changes in the epigenome. The question in cancer epigenetics is that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c38dabd3e7dec592fac338baf3f764ac
https://doi.org/10.1007/978-1-4614-0254-1_8
https://doi.org/10.1007/978-1-4614-0254-1_8
Autor:
Moshe Szyf, Flora Chik
Publikováno v:
Carcinogenesis. 32(2)
A hallmark of cancer is aberrant DNA methylation, consisting of global hypomethylation and regional hypermethylation of tumor suppressor genes. DNA methyltransferase inhibitors have been recognized as promising candidate anticancer drugs. Drug develo